
Tuesday, January 30, 2018 1:01:21 PM
Recent RCKT News
- Rocket Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference • Business Wire • 04/03/2025 11:00:00 AM
- Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress • Business Wire • 02/27/2025 09:01:00 PM
- Rocket Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference • Business Wire • 01/02/2025 09:00:00 PM
- Rocket Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock • Business Wire • 12/11/2024 12:00:00 PM
- Rocket Pharmaceuticals Announces Proposed Public Offering of Common Stock • Business Wire • 12/10/2024 09:01:00 PM
- Rocket Pharmaceuticals to Participate in the 7th Annual Evercore HealthCONx Conference • Business Wire • 11/26/2024 12:00:00 PM
- Rocket Pharmaceuticals Announces New England Journal of Medicine Publication of Phase 1 RP-A501 Long-Term Data and Presents at Late-Breaking Scientific Sessions at 2024 American Heart Association Conference • Business Wire • 11/18/2024 04:00:00 PM
- Rocket Pharmaceuticals to Present Updated Data from the Phase 1 Clinical Trial of RP-A501 for Danon Disease at the American Heart Association’s 2024 Late-Breaking Science Sessions • Business Wire • 11/12/2024 09:01:00 PM
- Rocket Pharmaceuticals to Participate in the UBS Global Healthcare Conference • Business Wire • 11/08/2024 12:00:00 PM
- Rocket Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Progress • Business Wire • 11/07/2024 09:01:00 PM
- Rocket Pharmaceuticals Announces Completion of Enrollment in Phase 2 Pivotal Trial of RP-A501 for the Treatment of Danon Disease • Business Wire • 09/17/2024 11:00:00 AM
- Rocket Pharmaceuticals Announces Appointment of Mikael Dolsten, M.D., Ph.D., to Board of Directors • Business Wire • 09/10/2024 11:00:00 AM
- Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences • Business Wire • 08/27/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 08:26:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 08:26:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 08:26:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 08:26:32 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 08/16/2024 08:06:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/16/2024 07:39:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/16/2024 07:29:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/16/2024 07:23:21 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/16/2024 07:16:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 08:15:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 08:17:36 PM
- Rocket Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Progress • Business Wire • 08/05/2024 08:01:00 PM
Opus Holdings Unveils Powerhouse Leadership Team to Drive Aggressive Growth and Transform Market Trajectory • CATV • Apr 22, 2025 8:30 AM
Glidelogic Corp. (OTCQB: GDLG) Highlights Independent SOTA Evaluation of ResearchMind Platform • GDLG • Apr 22, 2025 6:54 AM
UAV Corp to Launch Inflation Test of SA-70 Airship This Week-A Gateway to High-Value Government and Defense Contracts • UMAV • Apr 21, 2025 1:30 PM
VAYK Corrects Major Clerical Error to Report $668K Operating Revenue for 2024 • VAYK • Apr 17, 2025 9:00 AM
UAV Corp Names David Dugas as President and Chief Operating Officer • UMAV • Apr 17, 2025 8:30 AM
Yuengling's Ice Cream Corporation (OTC: YCRM), Doing Business as ReachOut, Files 2024 10-K With Profitability, Growth, and Corporate Transformation in Focus • YCRM • Apr 16, 2025 11:07 AM